ScottD.PendergastMD

PubMed

• 9 citations
  Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular d...
  Joseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou
  International Journal of Retina and Vitreous. 2023-02-01
• One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
  Joseph M Coney, Jasmyne E McCoy, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou
  Clinical Ophthalmology. 2023-01-01
• 36 citations
  Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17
  Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten
  Ophthalmology. 2019-02-01

Journal Articles

• Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, et al; Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT)..., Ophthalmology, 1/1/2015
• Subretinal hyperreflective material in the Comparison of Age-Related Macular Degeneration Treatments Trials  
  Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2015
• Ciliary neurotrophic factor (CNTF) for macular telangiectasia Type 2 (MacTel): Results from a phase I safety trial  
  Chew EY, Clemons TE, Peto T, Sallo FB, Ingerman A, Tao W, Singerman L, Schwartz SD, Peachey NS, Bird AC; MacTel-CNTF Research Group, Am J Ophthalmol, 1/1/2015
• Effect of pegaptanib sodium 03 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from VISION study  
  Boyer DS, Goldbaum M, Leys AM, Starita C; for the V.I.S.I.O.N. Study Group, Br J Ophthalmol, 1/1/2014
• VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (...  
  Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, JAMA Ophthalmol, 1/1/2014
• Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG; CATT Research Group, Am J Ophthalmol, 1/1/2014
• The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/E...  
  Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME; DCCT/EDIC Research Group, Diabetes Care, 1/1/2013
• Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration  
  Ying GS, Huang J, Maguire MG, et al; omparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)  
  Hagstrom SA, Ying GS, Pauer GJ, et al; Comparison of AMD Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?  
  Niskopoulou M, Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T; MacTel Study Group, Br J Ophthalmol, 1/1/2013
• Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)  
  Danis RP, Domalpally A, Chew EY, et al; AREDS2 Study Group, Invest Ophthalmol Vis Sci, 1/1/2013
• Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials  
  Jaffe GJ, Martin DF, Toth CA,et al; Comparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia  
  Verhoeven VJ, Hysi PG, Wojciechowski R,et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nat Genet, 1/1/2013
• The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study  
  Orchard TJ, Lyons TJ, Cleary PA, et al; DCCT/EDIC Research Group, Diabetes Care, 1/1/2013
• Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error  
  Cheng CY, Schache M, Ikram MK, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions, and Complications Research Group, Am J Hum Genet, 1/1/2013
• Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials  
  Maguire MG, Daniel E, Shah AR, Grunwald JE, et al; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group), Ophthalmology, 1/1/2013
• Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions  
  Nathan DM, Bayless M, Cleary P, et al; DCCT/EDIC Research Group, Diabetes, 1/1/2013
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results  
  Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford..., Ophthalmology, 1/1/2012
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration  
  CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ, N Engl J Med, 1/19/2011
• Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results  
  Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J, Ophthalmology, 1/1/2011
• Incidences of neovascular events in eyes with retinal vein occlusion  
  Chan CK, Ip MS, Vanveldhuisen PC, Oden NL, Scott IU, Tolentino MJ, Blodi BA; SCORE Study Investigator Group, Ophthalmology, 1/1/2011
• Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes  
  DCCT/EDIC Research Group, de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B, N Engl J Med, 1/1/2011
• Retinal crystals in type 2 idiopathic macular telangiectasia  
  Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UE, Dubra A, Williams DR, Clemons T, Pauleikhoff D, Bird AC, Peto T; MacTel Study Group, Ophthalmology, 1/1/2011
• Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration  
  Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin ..., Proc Natl Acad Sci U S A, 1/20/2010
• Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study  
  Friberg TR, Tolentino M; LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M, Br J Ophthalmol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Current Ocular Therapy 
  Chapter: Choroidal ruptures. 
  Page 313 - 314Pendergast SD, Singerman LJEditors: Fraunfelder FT, Roy H.WB Saunders Company, Philadelphia2000
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Laser management of less common macular diseases. 
  Page 111 - 128Niffenegger JH, Pendergast SD, Singerman LJEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Photocoagulation of other causes of choroidal neovascularization. 
  Page 91 - 110Niffenegger JH, Pendergast SD, Singerman LJEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Laser management of branch and central retinal vein occlusions. 
  Page 67 - 76Zegarra H, Finkelstein D, Singerman LJ, Niffenegger JH, Pendergast SDEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Lasers in the treatment of proliferative retinopathies. 
  Page 35 - 53Pendergast SD, Singerman LJ, Niffenegger JH, Zegarra HEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Lasers in vitreous surgery. 
  Page 153 - 163Pendergast SD, Zakov ZN, Novak MAEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Macular Hole: Pathogenesis, Diagnosis and Treatment 
  Chapter: Complications in macular hole surgery. 
  Page 155 - 168Pendergast SD, Williams GAEditors: McCuen BW, Madreperla SA.Butterworth Heineman, Boston1998
• Vitreo-Retinal and Uveitis Update. Proceedings of the New Orleans Academy of Ophthalmology Symposium 
  Chapter: Central retinal vein occlusion. 
  Page 259 - 267Zegarra H, Singerman LJ, Pendergast SDEditors: Saer JB.Kugler Publications, The Hague1998
• Vitreo-Retinal and Uveitis Update. Proceedings of the New Orleans Academy of Ophthalmology Symposium 
  Chapter: Laser treatment of proliferative retinopathies. 
  Page 97 - 121Pendergast SD, Singerman LJ, Niffenegger JH, Zegarra HEditors: Saer JB.Kugler Publications, The Hague1998
• Glaucoma Update V 
  Chapter: Reproducibility of optic nerve head topographical measurements with the Glaucoma-Scope. 
  Pendergast SD, Shields MBEditors: Krieglstein GK.Kaden, Heidelberg1995
• Join now to see all

Abstracts/Posters

• Identification of a missense mutation in the Norrie's disease gene associated with advanced retinopathy of prematurity.
  Pendergast SD, Shastry BS, Hartzer MK, Trese MT, Research Forum, William Beaumont Hospital, 1/5/1996
• Effect of intravitreal suramin on a rabbit model of proliferative vitreoretinopathy.
  T. Hassan, Pendergast SD, Hartzer M, Cheng M, Invest Ophthalmol Vis Sci, 1/1/1996
• Fluid-gas exchange following intravitreal plasmin injection in a rabbit model.
  Pendergast SD, Hartzer M, Dailey W, Williams GA, M Cheng M, Trese MT, Invest Ophthalmol Vis Sci, 1/1/1996
• Surgical management of familial exudative vitreoretinopathy.
  Pendergast SD, Trese MT, Ophthalmology, 1/1/1996
• Visual field loss following macular hole surgery.
  Pendergast SD, McCuen BW II, Ophthalmology, 1/1/1995
• ERG changes in patients with long-standing diabetes and early diabetic retinopathy.
  Wu G, Pendergast SD, Roh S-Y, Gutierrez J, Brodie SE, ARVO Meeting, Sarasota, FL, 1/5/1991
• Practice patterns in the treatment of diabetic retinopathy in a referral population.
  Charles JB, Wu G, Roh S-Y, Gutierrez J, Pendergast SD, Weiter JJ, Invest Ophthalmol Vis Sci, 1/1/1991
• ERG changes in patients with long-standing diabetes mellitus and early diabetic retinopathy.
  Wu G, Pendergast SD, Roh S-Y, Gutierrez J, Brodie SE, Invest Ophthalmol Vis Sci, 1/1/1991
• Join now to see all

Lectures

• Clinical update on Fovista. 
  Warren, OH - 1/1/2015
• Retinal emergencies. 
  Warren, OH - 1/10/2013
• Evaluation and treatment of retinal vein occlusion. 
  Beachwood, OH - 1/25/2010
• Interesting retinal vascular cases. 
  Beachwood, OH - 1/21/2008
• Update on Lucentis and Avastin in the treatment of neovascular age-related macular degeneration. 
  Beachwood, OH - 1/15/2007
• Role of anti-VEGF agents in retinal disorders. 
  Youngstown, OH - 1/5/2007
• Update on anti-VEGF therapies in age-related macular degeneration. 
  Beachwood, OH - 1/25/2006
• The role of anti-VEGF therapy for the treatment of exudative AMD. 
  Cleveland, OH - 1/15/2006
• Retinal degenerations. 
  Beachwood, OH - 1/9/2006
• Hereditary vitreoretinal degenerations. 
  1/1/2006
• Macugen for AMD: VISION study results and exploratory analysis. 
  Albuquerque, NM - 1/20/2005
• Macugen for age-related macular degeneration: two year results. 
  Beachwood, OH - 1/15/2005
• Update on Visudyne therapy. 
  Boardman, OH - 1/14/2005
• VEGF and its role in AMD: Implications for therapeutics. 
  Albany, NY - 1/11/2005
• The genetics of macular degeneration. 
  Solon, OH - 1/4/2005
• Vascular endothelial growth factor: its role in ocular disease and implications for therapeutic intervention. 
  1/2/2005
• Management of vasoproliferative and neovascular ocular disorder: case studies. 
  Beachwood, OH - 1/19/2004
• The role of vascular endothelial growth factor in ocular disease. 
  Columbus, OH - 1/15/2004
• Implantable Miniature Telescope (IMT™): an update. 
  Independence, OH - 1/10/2004
• Intravitreal steroid injection for refractory cystoid macular edema. 
  Porto Carras, Chalkidiki, Greece - 1/9/2004
• Intravitreal Kenalog injection for cystoid macular edema. 
  Youngstown, OH - 1/6/2004
• New treatments for diabetic macular edema. 
  Beachwood, OH - 1/1/2003
• Update on diabetic retinopathy. 
  Lorain, OH - 1/15/2002
• Intravitreal injection of anti-angiogenic agents for age-related macular degeneration. 
  Lorain, OH - 1/1/2002
• New horizons in the treatment of diabetic retinopathy. 
  Richfield, OH - 1/1/1999
• Join now to see all